ESTUDO FINAL DE PACIENTES HOSPITALIZADOS PUBLICADO

Nosso estudo final em pacientes hospitalizados, com pacientes do Norte e do Sul do Brasil, foi publicado no sábado, dia 25/dez/2021, Publicamos no Cureus. Saibam que nós ESCOLHEMOS o Cureus. Foi nossa PRIMEIRA OPÇÃO.
E sabem o por quê? Porque o Cureus mostrou-se, ao menos neste momento, entre as revistas científicas mais técnicas, sérias, apolíticas e sem influências de interesses secundários. Tenho documentação mais que suficiente para embasar o que estou dizendo.
Foram 03 etapas editoriais, mais um comitê editorial, mais revisores verdadeiramente independentes, múltiplos ajustes importantes, e, por fim, a garantia de transparência com a publicação de absolutamente todos os dados, que aceitaram nossa publicação.
Ainda iremos publicar os resultados específicos do Norte e do Sul, em dois “estudos” (papers) separados.
Irei postar slide a slide, aos poucos, em português e em inglês, para ajudar a entender o que nós apresentamos.
Espero que gostem!

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Flavio A. Cadegiani, MD, MSc, Ph.D.

Flavio A. Cadegiani, MD, MSc, Ph.D. Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @FlavioCadegiani

27 Dec
1/26 Kintor announces the first partial analysis of the study with proxalutamide in outpatients.

The results? POSITIVE (very positive if we consider the current scenario)
2/26 Why do you consider the results positive if Kintor said they "didn't reach statistical significance"?
Due to the reduction in overall hospitalization rates, I was hoping that the study would even be interrupted because it wouldn’t be able to show the differences we found.
3/26 1. A. This is the study with outpatients, which evaluated whether proxalutamide prevented hospitalizations. There were very few hospitalizations among patients who were included in the research.
Read 24 tweets
25 Jul
The androgen theory on COVID-19 and anti-androgens as promising therapies for COVID-19: the (almost) full story. (Thread - ENGLISH VERSION)
1/44 Studies with proxalutamide resulted from a solidly constructed scientific knowledge pathway. In this thread, I briefly describe the process from the beginning.
2/44 Since the beginning of the pandemics, men were found to be at higher risk for severe COVID-19, irrespective of other risk factors. Image
Read 55 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(